These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18434399)

  • 21. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
    Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
    Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
    Baumert TF; Rösler C; Malim MH; von Weizsäcker F
    Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
    Meier MA; Suslov A; Ketterer S; Heim MH; Wieland SF
    J Viral Hepat; 2017 Aug; 24(8):662-671. PubMed ID: 28182305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice.
    Peltekian C; Gordien E; Garreau F; Meas-Yedid V; Soussan P; Willams V; Chaix ML; Olivo-Marin JC; Bréchot C; Kremsdorf D
    J Hepatol; 2005 Dec; 43(6):965-72. PubMed ID: 16168514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.
    McClary H; Koch R; Chisari FV; Guidotti LG
    J Virol; 2000 Mar; 74(5):2255-64. PubMed ID: 10666256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro.
    Bonvin M; Greeve J
    J Gen Virol; 2007 Dec; 88(Pt 12):3270-3274. PubMed ID: 18024895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.
    Gallay P; Ure D; Bobardt M; Chatterji U; Ou J; Trepanier D; Foster R
    PLoS One; 2019; 14(6):e0217433. PubMed ID: 31181107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
    Proto S; Taylor JA; Chokshi S; Navaratnam N; Naoumov NV
    Antiviral Res; 2008 Jun; 78(3):260-7. PubMed ID: 18313151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
    Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
    Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
    Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
    J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
    Kanagaraj A; Sakamoto N; Que L; Li Y; Mohiuddin M; Koura M; Wakae K; Kurachi M; Muramatsu M; Kitamura K
    Biochem Biophys Res Commun; 2019 Oct; 518(1):26-31. PubMed ID: 31400856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human APOBEC1 cytidine deaminase edits HBV DNA.
    Gonzalez MC; Suspène R; Henry M; Guétard D; Wain-Hobson S; Vartanian JP
    Retrovirology; 2009 Oct; 6():96. PubMed ID: 19843348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Patterson AP
    J Biol Chem; 2021 Aug; 297(2):100889. PubMed ID: 34181944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral effects of a niobium-substituted heteropolytungstate on hepatitis B virus-transgenic mice.
    Li Q; Zhang H; Qi Y; Wang J; Li J; Niu J
    Drug Dev Res; 2019 Dec; 80(8):1062-1070. PubMed ID: 31396981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression.
    Bai L; Nong Y; Shi Y; Liu M; Yan L; Shang J; Huang F; Lin Y; Tang H
    Mol Pharm; 2016 Feb; 13(2):568-77. PubMed ID: 26656210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Choi YM; Kim H; Lee SA; Lee SY; Kim BJ
    Front Immunol; 2020; 11():652. PubMed ID: 32508804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.